High-risk neuroblastoma as a model for immunotherapy of non-immunogenic cancers: where might we be in 20 years?
Children and adults diagnosed with malignancies that are not curable in 2025 with surgery alone require multimodal therapy. For decades, this has included radiation therapy and/or chemotherapy. This approach can be curative for many patients with cert…